Skip to content

Lobbying by EXKA Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Corporation

EXKA Inc.

Meetings this Parliament
1
With MPs
0
Since Nov 2021
5
Active registrations
1

Most recent reported meeting: Oct 30, 2025.

Who they meet

Since the current Parliament opened.

Institutions

  • House of Commons1

Registrations in effect

In-house (corporation) In effect since Mar 24, 2026 Receives government funding

Filed by Maxime Paris, President and CEO

Lobbyists

  • Dominic Laflamme · Vice-Président Ventes et Marketing
  • Maxime Paris · President and CEO
  • Sebastien Desormeau · Vice-President, Chief Business Developement Officer

Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Business Development Bank of Canada (BDC), Canada Economic Development for Quebec Regions, Export Development Canada (EDC), Farm Credit Canada (FCC), Global Affairs Canada (GAC), Health Canada (HC), House of Commons

What they're lobbying on (1)
  • EXKA lobbyists could talk to political stakeholders and authorities to discuss / comment / influence a policy or program related to cannabis funding and medical cannabis legal framework

Registration 950355-370489-12. Look it up in the official Registry

Reported meetings

Spreadsheet
  • Reported by Maxime Paris · In-house (corporation)

    • Nathaniel Erskine-Smith · Député, House of Commons
    EXKA lobbyists could talk to political stakeholders and authorities to discuss / comment / influence a policy or program related to cannabis funding and medical cannabis legal framework Read more

    Official report

  • Reported by Maxime Paris · In-house (corporation)

    Health Canada regarding the Cannabis Act (C-45) for medicinal cannabis & Cannabis Act (C-45) and its regulation to strengthen the framework of medical cannabis use: - EXKA lobbyists could talk to political stakeholders and authorities to discuss / comment / influence a policy or program related to cannabis funding and medical cannabis legal framework Read more

    Official report

  • Reported by Maxime Paris · In-house (corporation)

    • Rebecca Patterson · Senator, House of Commons

    Health

    Official report

  • Reported by Maxime Paris · In-house (corporation)

    Health

    Official report

  • Reported by Maxime Paris · In-house (corporation)

    • Dylan Bissonnette · Senior manager politiques de la santé, Health Canada (HC)
    • Eshan Naik · Directeur des politiques, Health Canada (HC)

    Health

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.